YouSigma- the web's most extensive resource for information
$6.99 Domain Names at Network SolutionsĀ®!
Celgene Corporation (SWOT Analysis)

Go to Home Page

Tell your friend about this WebSite!

Download PDF Version!

“SWOT is an acronym for the internal Strengths and Weaknesses of a firm and the environmental Opportunities and Threats facing that firm. SWOT analysis is a widely used technique through which managers create a quick overview of a company’s strategic situation. The technique is based on the assumption that an effective strategy derives from a sound “fit” between a firm’s internal resources (strengths and weaknesses) and its external situation (opportunities and threats). A good fit maximizes a firm’s strengths and opportunities and minimizes its weaknesses and threats. Accurately applied, this simple assumption has powerful implications for the design of a successful strategy.”

Celgene Corporation

Celgene, an integrated biopharmaceutical company, discovers, develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company primarily operates in the US. The company is headquartered in Summit, New Jersey and employes about 2,441 people.

Strengths, Weaknesses, Opportunities and Threats (SWOT)

Location of Factor

TYPE OF FACTOR

Favorable

Unfavorable

Internal

Strengths

  • Pharmion acquisition brings Thalomid (EU rights), Vidaza and amrubicin, and existing operating infrastructure
  • Potential to reduce operating costs as a percentage of total revenue

Weaknesses

  • Significant operating loss reported in 2008

External

Opportunities

  • Negative trial data for SuperGen/Eisai’s
  • Dacogen to boost Vidaza uptake
  • Development of key products for Japanese market

Threats

  • Reliance on Revlimid for majority of company growth
  • Small molecule portfolio susceptible to generic competition
  • Revlimid and Thalomid face competition from J&J/Millennium’s Velcade
  • Dependence on third-party reimbursement
underline
About YouSigma Please Donate Using PayPal, to help us Develop Content
Copyright and Disclaimer
Loading
underline
underline
Try a free sample Destiny Reading! Executive Openings! $80,000 to $500,000+
"Celgene Corporation (SWOT Analysis)";